Wisløff, Torbjørn <br/><br/>
Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.  [electronic resource] 

 -  Vaccine  Jul 2006 
 - 5690-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2006.04.042  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bacteremia--economics<br/>Cost-Benefit Analysis<br/>Heptavalent Pneumococcal Conjugate Vaccine<br/>Humans<br/>Immunity, Herd<br/>Immunization Programs--economics<br/>Markov Chains<br/>Meningitis, Pneumococcal--economics<br/>Meningococcal Vaccines--administration & dosage<br/>Norway<br/>Pneumococcal Infections--economics<br/>Pneumococcal Vaccines--administration & dosage<br/>Vaccination--economics<br/>Vaccines, Conjugate--administration & dosage